Adma Biologics News and Activities
Presence
Adma Biologics develops and sells plasma-based biologic medicines. Its products and services include immune deficiency therapies and plasma collection for hospitals, clinics, and patients with weakened immune systems.
Adma Biologics products and services overview:
- Plasma therapies
- Immune globulin products
- Biologic medicines
- Plasma collection services
Revenue: ~$427 million
Employees: 650
Headquarters: Ramsey, United States (USA)
Adma Biologics is one of the...
Adma Biologics is a company listed under the stock ticker ADMA (US).
Executives
View the org chart displaying its 24 main executives
Most searched biographies at Adma Biologics
- Adam Grossman, Founder, Director, President and Chief Executive Of...
- Steven Elms, Chairman of the Board
- Eduardo Salas, Director
Popular executive movements at Adma Biologics
- Cindy Petersen, Executive Director, Human Resources, has left the company (posted on April 16 2026).
Create your alert
to follow the executive moves at Adma Biologics.
Biotechnology
Adma Biologics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
Popular contacts in Biotechnology
News
Press releases by Adma Biologics
- ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older | ADMA Biologics, Inc.
- ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update | ADMA Biologics, Inc.
- ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026 | ADMA Biologics, Inc.
- ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update | ADMA Biologics, Inc.
- ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023 | ADMA Biologics, Inc.
- Press Releases | ADMA Biologics, Inc.
- Press Releases | ADMA Biologics, Inc.
- ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update | ADMA Biologics, Inc.
- ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023 | ADMA Biologics, Inc.
- ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
- View more press releases Close
Social media about Adma Biologics
- Adma Biologics on Wikipedia, Google News & Yahoo Finance
- Adma Biologics on LinkedIn, X (Twitter) & YouTube
